Medicilon Intermediate Synthesis Service

As a provider of global chemical services, Medicilon has a strong analytical chemistry team to support synthetic chemistry services. We are committed to providing customers with the highest quality and most valuable products and services through prolific, fast, problem-solving and active communication. Our team has received excellent professional training, keeps close contact and interaction with customers, communicates in time to ensure the smooth progress of the project, and makes concerted efforts to achieve the project goals specified by the customer. In FTE’s service model, we design a synthetic route for the customer’s target molecule, and complete the synthesis and delivery of the compound on time, quality and quantity. These compounds include reference compounds, metabolites, reagents, intermediates, molecular fragments and impurities.

Pharmaceutical Intermediate Synthesis

Medicilon synthesizes various small molecule chemical substances such as reference compounds, pharmaceutical intermediates, candidate drugs, impurities and metabolites for customers. The scale can range from milligrams to kilograms (including GMP quality). Our team is proficient in new route design and route optimization. With the proficient problem solving skills and the high success rate of the project, we are able to provide customers with the following high-quality chemical custom synthesis services:

Preparation of high-quality products from milligrams to kilograms
Synthesis of special reagents and pharmaceutical intermediates and preparation of molecular fragments
Preparation of APIs or related substances
Synthetic design and preparation of impurities and metabolites
Analysis support
Delivery of product analysis report

Click for service details

Medicilon’s chemical department is mainly engaged in the research and development and process optimization of high value-added new pharmaceutical intermediates, the research and development and process optimization of fine chemicals and the synthesis of raw materials, and is especially committed to natural products, special reagents, pharmaceutical intermediates, and pharmaceutical intermediates required for the research and development of new drugs. As well as the laboratory synthesis and amplification of various sugar compounds, the company has a factory base and advanced test equipment. The company has a comprehensive literature retrieval system, highly specialized chemical synthesis and process development capabilities, and high-level synthetic technical personnel.

Pharmaceutical intermediates, generally speaking, refer to those key raw materials specifically used to produce drugs, such as the key intermediates 6-APA (6-aminopenicillanic acid), 7-ACA (7-amino Cephalosporan acid), 7-ADCA (7-aminodeacetoxycephalosporan acid), various cephalosporin side chains, and piperazine and its derivatives used in the production of quinolones, excluding those used Basic chemical raw materials used in drug production, such as ethanol and acetic acid.

Medicines can be divided into anti-cardiovascular drugs, anti-tumor drugs, endocrine system regulating drugs, antibiotics, etc. according to their uses, and each class of drugs contains a variety of drugs with different structures, such as: antibiotics including lactams, macrocyclic Esters, quinolones, chloramphenicol, etc. Since pharmaceutical intermediates are mainly used in the production of various drugs, they have a wide variety of types.

From the perspective of production, the pharmaceutical industry can be divided into two major categories: raw material drug production and preparation processing; raw material drug production can be divided into natural drugs and chemical drugs according to source, and can be divided into natural extracted drugs, biosynthetic drugs and chemically synthesized drugs according to production methods.

Phone: 02158591500

This article is about the synthesis of pharmaceutical intermediates and pharmaceutical intermediates. For more details, please contact us.

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration. The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies, ADCs , mRNA vaccines , small nucleic acid drugs , PROTAC , and CGT technical service platform that have helped 421 INDs obtain clinical approval. It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

阅读全文

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...

阅读全文

What is Toxicokinetics?

Toxicokinetics is essentially the study of “how a substance gets into the body and what happens to it in the body”. Four processes are involved in toxicokinetics. The study of the kinetics (movement) of chemicals was originally conducted with pharmaceuticals and thus the term pharmacokinetics became commonly used. In addition, toxicology studies were initially conducted with drugs. However, the science of toxicology has evolved to include environmental and occupational chemicals as well as drugs. Toxicokinetics is thus the appropriate term for the study of the kinetics of all toxic substances. Frequently the terms toxicokinetics , pharmacokinetics , or disposition may be found in the literature to have the same meaning. Disposition is often used in place of toxicokinetics to describe the time-course of movement of chemicals through the body (that is, how does the body dispose of a xenobiotic?). The disposition of a toxicant along with its’ biological reactivi...

阅读全文

Shanghai Medicilon Inc.

搜索此博客